On Monday, DocuSign got an upgrade for its IBD SmartSelect Composite Rating from 92 to 97.
The revised score means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. The best stocks tend to have a 95 or better grade as they launch a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
DocuSign has now climbed above a proper buy zone after breaking out from a consolidation.
Looking For The Best Stocks To Buy And Watch? Start Here
The stock earns a 93 EPS Rating, meaning its recent quarterly and annual earnings growth is outpacing 93% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
In Q4, the company posted 13% EPS growth. Sales growth increased 9%, up from 8% in the prior quarter. The company has now posted accelerating growth in each of the last two quarters.
DocuSign earns the No. 2 rank among its peers in the Computer Software-Enterprise industry group. Palantir Technologies is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
